Therapeutic Potential of Leaves from Fridericia chica (Bonpl.) L. G. Lohmann: Botanical Aspects, Phytochemical and Biological, Anti-Inflammatory, Antioxidant and Healing Action

Biomolecules. 2022 Aug 31;12(9):1208. doi: 10.3390/biom12091208.

Abstract

Plants of the species Fridericia chica (Bonpl.) L. G. Lohmann (Bignoniaceae), which are widely distributed in Brazil and named crajiru in the state of Amazonas, are known in folk medicine as a traditional medicine in the form of a tea for the treatment of intestinal colic, diarrhea, and anemia, among other diseases. The chemical analysis of extracts of the leaves has identified phenolic compounds, a class of secondary metabolites that provide defense for plants and benefits to the health of humans. Several studies have shown the therapeutic efficacy of F. chica extracts, with antitumor, antiviral, wound healing, anti-inflammatory, and antioxidant activities being among the therapeutic applications already proven. The healing action of F. chica leaf extract has been demonstrated in several experimental models, and shows the ability to favor the proliferation of fibroblasts, which is essential for tissue repair. The anti-inflammatory activity of F. chica has been clearly demonstrated by several authors, who suggest that it is related to the presence of 3-deoxyanthocyanidins, which is capable of inhibiting pro-inflammatory pathways such as the kappa B (NF-kB) nuclear transcription factor pathway. Another important effect attributed to this species is the antioxidant effect, attributed to phenolic compounds interrupting chain reactions caused by free radicals and donating hydrogen atoms or electrons. In conclusion, the species Fridericia chica has great therapeutic potential, which is detailed in this paper with the objective of encouraging new research and promoting the sum of efforts for the inclusion of herbal medicines in health systems around the world.

Keywords: Fridericia chica; anti-inflammatory; antioxidant; phytochemistry; wound healing.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / analysis
  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants* / chemistry
  • Antiviral Agents / pharmacology
  • Bignoniaceae* / chemistry
  • Humans
  • Hydrogen
  • NF-kappa B
  • Phenols / analysis
  • Phenols / pharmacology
  • Phytochemicals / pharmacology
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • Tea
  • Wound Healing

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Antiviral Agents
  • NF-kappa B
  • Phenols
  • Phytochemicals
  • Plant Extracts
  • Tea
  • Hydrogen

Grants and funding

The following agencies founded the present work: Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM) for the funding, CT&I Priority Areas Call FAPEAM 010/2021 for MAS and HHFK, and HHFK’s research under the Universal Call FAPEAM-006/2019. HHFK and WMM acknowledge FAPEAM for funding via the calls PAPAC 005/2019, PRO-ESTADO-002/2008; 007/2018; 005/2019 and POSGRAD 2020-2021.